128 related articles for article (PubMed ID: 36369248)
1. Corrigendum to DNA methylation-induced ablation of miR-133a accelerates cancer aggressiveness in glioma through upregulating peroxisome proliferator-activated receptor γ [SLAS Discov. 2022 Sep 5;S2472-5552(22)13691-9. doi: 10.1016/j.slasd.2022.08.004.].
Liu L; Zhu Z; Li X; Zheng Y
SLAS Discov; 2023 Jan; 28(1):48. PubMed ID: 36369248
[No Abstract] [Full Text] [Related]
2. DNA methylation-induced ablation of miR-133a accelerates cancer aggressiveness in glioma through upregulating peroxisome proliferator-activated receptor γ.
Liu L; Zhu Z; Li X; Zheng Y
SLAS Discov; 2023 Jan; 28(1):19-28. PubMed ID: 36067936
[TBL] [Abstract][Full Text] [Related]
3. Impaired exercise tolerance, mitochondrial biogenesis, and muscle fiber maintenance in miR-133a-deficient mice.
Nie Y; Sato Y; Wang C; Yue F; Kuang S; Gavin TP
FASEB J; 2016 Nov; 30(11):3745-3758. PubMed ID: 27458245
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-130b promotes cell migration and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma.
Li P; Wang X; Shan Q; Wu Y; Wang Z
Oncol Lett; 2017 Apr; 13(4):2615-2622. PubMed ID: 28454441
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-130b promotes cell migration and invasion by targeting peroxisome proliferator-activated receptor gamma in human glioma.
Sheng X; Chen H; Wang H; Ding Z; Xu G; Zhang J; Lu W; Wu T; Zhao L
Biomed Pharmacother; 2015 Dec; 76():121-6. PubMed ID: 26653558
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma.
Nishida K; Furumatsu T; Takada I; Kawai A; Yoshida A; Kunisada T; Inoue H
Br J Cancer; 2002 Apr; 86(8):1303-9. PubMed ID: 11953889
[TBL] [Abstract][Full Text] [Related]
7. miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.
Sakr M; Takino T; Sabit H; Nakada M; Li Z; Sato H
Gene; 2016 Aug; 587(2):155-62. PubMed ID: 27154818
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes.
Chavali V; Tyagi SC; Mishra PK
Biochem Biophys Res Commun; 2012 Aug; 425(3):668-72. PubMed ID: 22842467
[TBL] [Abstract][Full Text] [Related]
9. Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.
Lenman A; Fowler CJ
Br J Pharmacol; 2007 Aug; 151(8):1343-51. PubMed ID: 17592505
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma and BRCA1.
Furth PA
Endocr Relat Cancer; 2019 Feb; 26(2):R73-R79. PubMed ID: 30444720
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
Burton JD; Castillo ME; Goldenberg DM; Blumenthal RD
Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
[TBL] [Abstract][Full Text] [Related]
12. lncRNA XIST promotes glioma proliferation and metastasis through miR-133a/SOX4.
Luo C; Quan Z; Zhong B; Zhang M; Zhou B; Wang S; Luo X; Tang C
Exp Ther Med; 2020 Mar; 19(3):1641-1648. PubMed ID: 32104215
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
Han S; Roman J
Anticancer Drugs; 2007 Mar; 18(3):237-44. PubMed ID: 17264754
[TBL] [Abstract][Full Text] [Related]
14. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease.
Tontonoz P; Nagy L
Curr Opin Lipidol; 1999 Dec; 10(6):485-90. PubMed ID: 10680041
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-130b promotes cell proliferation and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma cells.
Gu JJ; Zhang JH; Chen HJ; Wang SS
Int J Mol Med; 2016 Jun; 37(6):1587-93. PubMed ID: 27122306
[TBL] [Abstract][Full Text] [Related]
16. Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients.
Duca RB; Massillo C; Farré PL; Graña KD; Moro J; Gardner K; Lacunza E; De Siervi A
Front Oncol; 2022; 12():997457. PubMed ID: 36387263
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Peroxisome proliferator-activated receptor-α: A pivotal regulator of the gastrointestinal tract.
Guo YX; Wang BY; Gao H; Hua RX; Gao L; He CW; Wang Y; Xu JD
Front Mol Biosci; 2022; 9():1063551. PubMed ID: 36339724
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of benign biliary stricture inhibition by rosiglitazone-activated peroxisome proliferator-activated receptor gamma.
Jiamei L; Liang Y; Jianhua S
Rev Assoc Med Bras (1992); 2022; 68(10):1400-1404. PubMed ID: 36417643
[TBL] [Abstract][Full Text] [Related]
19. Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.
Chen Y; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y; Qian J
Diab Vasc Dis Res; 2017 Mar; 14(2):152-162. PubMed ID: 28111985
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinoma.
Liu R; Zhang H; Zhang Y; Li S; Wang X; Wang X; Wang C; Liu B; Zen K; Zhang CY; Zhang C; Ba Y
Tumour Biol; 2017 Apr; 39(4):1010428317695031. PubMed ID: 28381162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
